TD Cowen lowered the firm’s price target on Option Care Health (OPCH) to $27 from $30 and keeps a Hold rating on the shares. The firm updated its model following Q3 results as Stelara uncertainty suggests a more cautious 2026 outlook.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health’s Earnings Call Highlights Growth and Challenges
- Option Care Health price target lowered to $36 from $38 at Citizens JMP
- Option Care Health Reports Strong Q3 2025 Results
- Option Care Health: Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Option Care Health reports Q3 adjusted EPS 45c, consensus 43c